Document Detail

Syphilis Infection during pregnancy: fetal risks and clinical management.
Jump to Full Text
MedLine Citation:
PMID:  22829747     Owner:  NLM     Status:  MEDLINE    
Congenital syphilis is still a cause of perinatal morbidity and mortality. Untreated maternal infection leads to adverse pregnancy outcomes, including early fetal loss, stillbirth, prematurity, low birth weight, neonatal and infant death, and congenital disease among newborns. Clinical manifestations of congenital syphilis are influenced by gestational age, stage of maternal syphilis, maternal treatment, and immunological response of the fetus. It has been traditionally classified in early congenital syphilis and late congenital syphilis. Diagnosis of maternal infection is based on clinical findings, serological tests, and direct identification of treponemes in clinical specimens. Adequate treatment of maternal infection is effective for preventing maternal transmission to the fetus and for treating fetal infection. Prenatal diagnosis of congenital syphilis includes noninvasive and invasive diagnosis. Serological screening during pregnancy and during preconception period should be performed to reduce the incidence of congenital syphilis.
Marco De Santis; Carmen De Luca; Ilenia Mappa; Terryann Spagnuolo; Angelo Licameli; Gianluca Straface; Giovanni Scambia
Related Documents :
20978777 - Extreme gigantomastia in pregnancy: case report-my experience with two cases in last 5...
17513937 - Vaginal birth after cesarean delivery: evidence-based practice.
7235607 - The effect of education, marital status and sexual behaviour on the incidence of puerpe...
11451817 - Reliability and validity of chest radiograph surveillance programs.
23472497 - Renal disease and hypertension in pregnancy.
24627667 - Do clinical and laboratory parameters effect maternal and fetal outcomes in pregnancies...
Publication Detail:
Type:  Journal Article     Date:  2012-07-04
Journal Detail:
Title:  Infectious diseases in obstetrics and gynecology     Volume:  2012     ISSN:  1098-0997     ISO Abbreviation:  Infect Dis Obstet Gynecol     Publication Date:  2012  
Date Detail:
Created Date:  2012-07-25     Completed Date:  2012-10-24     Revised Date:  2013-07-12    
Medline Journal Info:
Nlm Unique ID:  9318481     Medline TA:  Infect Dis Obstet Gynecol     Country:  Egypt    
Other Details:
Languages:  eng     Pagination:  430585     Citation Subset:  IM    
Department of Obstetrics and Gynaecology, Università Cattolica del Sacro Cuore, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Infant, Low Birth Weight
Infant, Newborn
Infectious Disease Transmission, Vertical / prevention & control
Perinatal Mortality
Pregnancy Complications, Infectious / microbiology*
Premature Birth / etiology
Syphilis / complications*,  diagnosis,  transmission
Syphilis, Congenital / diagnosis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Infect Dis Obstet Gynecol
Journal ID (iso-abbrev): Infect Dis Obstet Gynecol
Journal ID (publisher-id): IDOG
ISSN: 1064-7449
ISSN: 1098-0997
Publisher: Hindawi Publishing Corporation
Article Information
Download PDF
Copyright © 2012 Marco De Santis et al.
Received Day: 15 Month: 3 Year: 2012
Accepted Day: 17 Month: 5 Year: 2012
Print publication date: Year: 2012
Electronic publication date: Day: 4 Month: 7 Year: 2012
Volume: 2012E-location ID: 430585
ID: 3398589
PubMed Id: 22829747
DOI: 10.1155/2012/430585

Syphilis Infection during Pregnancy: Fetal Risks and Clinical Management
Marco De Santis1*
Carmen De Luca1
Ilenia Mappa1
Terryann Spagnuolo1
Angelo Licameli1
Gianluca Straface2
Giovanni Scambia1
1Department of Obstetrics and Gynaecology, Università Cattolica del Sacro Cuore, Policlinico “A. Gemelli”, Rome, Italy
2Department of Obstetrics and Gynaecology, Policlinico Abano Terme, Abano Terme (PD), Italy
Correspondence: *Marco De Santis:
[other] Academic Editor: Francesco De Seta

1. Introduction

Syphilis is a sexually transmitted disease (STD) caused by the bacterium Treponema pallidum, but little is known about its mechanism of action or what determines virulence of infection [1]. Untreated syphilis in pregnancy leads to adverse outcomes among more than half of the women with active disease, including early fetal loss, stillbirth, prematurity, low birth weight, neonatal and infant death, and congenital disease among newborn babies [2]. In 2010, a total of 13,774 cases of primary and secondary syphilis were reported to Centers for Disease Control and Prevention [3]. According to World Health Organization (WHO), 12 million people were infected each year [4]. It was estimated that the lifetime medical cost per case of syphilis is $572 (in year 2006 dollars) and they could be much higher if CS and HIV infections occurred [5]. Screening and early detection can reduce these costs because treatment for early stage syphilis is less expensive than treatment for later stage disease: $41.26 (in year 2001 dollars) compared to $2,061.70 for late syphilis [6]. Moreover, CDC recommends that all persons who have syphilis should be tested for HIV infection [7]. Genital sores caused by syphilis can bleed easily and make it easier to transmit HIVinfection, with a 2- to 5-fold increased risk of acquiring HIV [8]. Changes in the population incidence of primary and secondary syphilis among women are usually followed by similar changes in the incidence of congenital syphilis (CS) [9]. CDC reported that the rates of both female and CS increased during 2005–2008 in the United States of America (USA), and have since declined. The rate of syphilis among women was 1.1 cases per 100,000 women in 2010, and the rate of CS was 8.7 cases per 100,000 live births in 2010 [10]. According to the most recent (2008) estimates from WHO, about 1.9 million pregnant women had active syphilis [11]. In Italy, the incidence rate of syphilis was 0.86 per 100,000 population in 2008 [12], and CS is strictly related to immigration, mostly from Eastern Europe. In 2007 an Italian prospective study on 19.548 pregnant women showed that the overall syphilis seroprevalence was 0.44% but it was 4.3% in women from Eastern Europe and 5.8% in women from Central-South America. This high prevalence could be explained by the fact that immigrant women do not always receive adequate prenatal care owing to lack of knowledge of free healthcare services [13].

Without screening and treatment, about 70% of infected women will have an adverse pregnancy outcome [14].

2. Clinical Manifestations

Clinical manifestations of acquired syphilis are not apparently altered by pregnancy. Syphilis is passed from person to person through direct contact with a syphilitic sore, called chancre. Transmission of the organism occurs during vaginal, anal, or oral sex. Sores of primary syphilis occur about 3 weeks after contact, mainly on the external genitals, vagina, cervix, anus, or in the rectum.They are often unrecognized in women because they can be asymptomatic. Syphilitic sore is firm, round, small, and painless and lasts 3 to 6 weeks. It should be distinguished by Genital Herpes, which causes small, painfulblistersfilled with clear or straw-colored fluid. When blisters break, they leave shallowulcersthat are very painful and eventually crust over and slowly heal over 7–14 days or more [2].

Sypilitic sore can increase the risk of HIV transmission by disrupting mucosal and epithelial barriers[15] and is followed several weeks or months later by widespread cutaneous, mucosal, and sometimes systemic indications of the dissemination of the spirochetes of secondary syphilis. This phase can last up to a year and syphilis is particularly contagious at this stage. Even without treatment both primary and secondary lesions resolve and the infection enters a latent stage. Despite the lack of clinical manifestations, the infection can still be transmitted to the fetus [2]. Tertiary syphilis may occur in a third of untreated people, approximately three to 15 years after the initial infection. It is characterized by infiltrative tumors of skin, bones, or liver (gumma) (15%), central nervous system disorders (neurosyphilis)   (6.5%), and cardiovascular problems (10%). People with tertiary syphilis are not infectious [16].

3. Fetal Infection

Spirochetes can cross the placenta and infect the fetus from about 14 weeks' gestation, and the risk of fetal infection increases with gestational age [17]. The manifestations of CS are influenced by gestational age, stage of maternal syphilis, maternal treatment, and immunological response of the fetus [18]. CS can lead to spontaneous abortion, usually after the first trimester, or late-term stillbirth in 30 to 40 percent of cases or premature or term delivery of live infants who may have obvious signs of infection or be fully asymptomatic (approximately two-thirds of liveborn cases) [19]. Placental infection and the reduction in blood flow to the fetus are the most common causes of fetal death. An untreated woman has about 70% of chance of fetal infection during the first 4 years of disease. In 35% of cases, infected fetuses are born alive with CS. Low birth weight can be the only sign of infection. In fact about 60% of liveborns are asymptomatic at birth [20, 21]. CS has been traditionally classified in early congenital syphilis (ECS) and late congenital syphilis (LCS). In ECS signs appear in the first 2 years of life while in LCS signs appear over the first 2 decades. Clinical manifestations of ECS are the result of active infection and inflammation while clinical manifestations of LCS are malformation or stigmata that represent the scars induced by initial lesions of ECS or can be the result of chronic inflammation [2]. After fetal infection occurs, any organ system can be affected because of the widespread spirochetal dissemination.

4. Early Congenital Syphilis

Hepatomegaly is present in nearly all infants with CS, while splenomegaly is present in half of cases. Jaundice has been recorded in 33% of cases, as a consequence of syphilitic hepatitis or of hemolytic anemia [2, 22]. Elevated serum transaminase and alkaline phosphatase concentrations and direct hyperbilirubinemia can occur; the prothrombin time may be prolonged [2325]. Generalized lymphadenopathy has been described in 50% of patients. Large epitrochlear nodes are typical of CS [22].

Hematological manifestations, such as anemia, thrombocytopenia, leukopenia, and leukocytosis are common findings in CS [2]. Hydrops fetalis may also be a manifestation. In presence of a negative coomb's test in a hydropic infant with hemolytic anemia CS should be considered [26].

Mucocutaneous involvement occurs in as many as 70% of infected infants and may be present at birth or develop during the first few weeks of life. The most common cutaneous manifestation consists of small copper-red maculopapular lesions, and the hands and feet often are most severely affected. Desquamation and crusting occur over the course of 1 to 3 weeks [2, 22]. Rhinitis may be an early symptom which appears after the first week of life and usually before the end of the third month. Mucus discharge is often is blood-tinged and secondary bacterial infections can occur. “Saddle nose” deformity is one of the later stigmata of the disease, and can occur when ulceration of nasal mucosa involves the nasal cartilage. All mucocutaneous lesions and discharges contain abundant spirochetes and are highly infectious. After the first 2 or 3 months of age, the perioral and the perineal area may be affected by wart-like or flat lesions called condyloma lata that can lead to deep fissures and can result in fine scars called rhagades [2, 27]. Petechial lesions may be seen if severe thrombocytopenia is present [22].

Bone involvement is very frequent in untreated ECS. The metaphyseal and diaphyseal portions of long bones are usually affected by periostitis and cortical demineralization, while osteochondritis involves the joints, especially knees, ankles, wrists, and elbows. Osteochondritis and periostitis may be painful and manifested by the pseudoparalysis of a limb due to pain (pseudoparalysis of Parrot), which affects more frequently the upper extremities [28].

A nephrotic syndrome can appear at 2 or 3 months of age, and it can lead to generalized edema [2].

Congenital neurosyphilismay be asymptomatic. More than 25 WBC/mm3 and protein greater than 150 mg/dL (170 mg/dL in premature infants) in cerebrospinal fluid (CSF) are considered suggestive of neurosyphilis although normal CSF indices do not exclude neurosyphilis. A reactive CSF Venereal Disease Research Laboratory (VDRL) test generally indicates the presence of neurosyphilis. CSF abnormalities are present in approximately 8 percent of asymptomatic infants born to mothers with untreated early syphilis [2, 29, 30].

Ocular manifestations are rare and include chorioretinitis, glaucoma, uveitis, cataract, salt and pepper fundus, and chancres of the eyelid. Other findings are less common [2].

5. Late Congenital Syphilis

LCS is actually very rare and occurs in approximately 40 percent of untreated children [2, 30].

Syphilitic vasculitis around the time of birth can lead to dental abnormalities that occur in teeth that undergo calcification during the first year of life. Hutchinson's teeth are peg-shaped, notched central incisors while mulberry molars are multicuspid first molars. The deciduous teeth have an increased risk of dental caries [30, 31].

Interstitial keratitis is the typical ocular manifestation, usually diagnosed between 5 and 20 years of age. It can lead to secondary glaucoma or corneal clouding [2].

Eight nerve deafness occurs in 3% of cases and is secondary to luetic involvement of the temporal bone. Eight nerve involvement can be unilateral or bilateral, and it may be responsive to corticosteroids. Although it is usually diagnosed between 30 and 40 years of age, it often occurs in the first decades [32].

The constellation of Hutchinson's teeth, interstitial keratitis and eight nerve deafness is called Hutchinson's triad [2], described by Sir Jonathan Hutchinson (1828–1913) from England. Fortunately, it actually represents a rare finding.

Syphilis rhinitis can impair the maxilla growth, resulting in an abnormal configuration in the middle section of the face, while nasal cartilage destruction resulting from inflammation can cause the perforation of the nasal septum and lead to saddle nose [2, 33].

Rhagades around the body orifices can result from the fissuration of early linear scares [31].

Neurological manifestations of LCS include mental retardation, hydrocephalus, convulsive disorders, cranial nerve abnormalities (including blindness and deafness), and juvenile general paresis [2, 27].

Bony involvement is less frequent than in ECS and it includes the sequelae of prolonged periostitis of the skull (resulting in frontal bossing), of the tibia (resulting in saber shin) and of the sternoclavicular portion of the clavicle (resulting in a deformity called Higouménakis sign).

Clutton's joints are symmetric, painless, sterile, synovitis usually localized to the knees and characterized by local tenderness and limitation of motion [2, 27, 31].

6. Diagnosis

Maternal syphilis can be suspected based on clinical findings and confirmed by direct identification of treponemes in clinical specimens and by positive serologic findings or can be accidently diagnosed through screening serological tests. Dark field microscopy is the most specific technique for diagnosing syphilis when an active chancre or condyloma latum is present [34]. Other possible methods include direct fluorescent antibody (DFA) testing and the rabbit infectivity test (not used in clinical practice) [2]. Serological tests for syphilis can be classified in nontreponemal (NTTs) and treponemal (TTs) tests. NTTs are usually used for screening and monitoring therapy, while TTs are used to confirm the diagnosis. Nontreponemal tests detect antibodies to cardiolipin, a component of membranes and mammalian tissue. The two commonly used nontreponemal tests are the Venereal Disease Research Laboratory (VDRL) and the Rapid Plasma Reagin (RPR) tests. False-positive reactions can occur because of pregnancy, autoimmune disorders, and infections [35]. NTTs are usually positive in 75% of cases of primary syphilis. Secondary syphilis is always characterized by a reactive VDRL, with a titer greater than 1/16 [2]. The titer of antibodies reflects disease activity: fourfold decrease suggests adequate therapy, while fourfold increase indicates active disease. NTTs usually become negative one year after receiving adequate treatment of primary syphilis and within two years with secondary syphilis. In a small percentage of patients low positive titers persist despite receiving adequate therapy [30]. TTs detect an interaction between serum immunoglobulins and surface antigens of Treponema pallidum. They include the fluorescent treponemal antibody absorption (FTA-ABS) test, the treponemal-specific microhemagglutination test (MHATP) and Treponema pallidum particle agglutination test (TP-PA). These tests are positive in 75% (TP-PA) to 85% (FTA-ABS) of patients with primary syphilis and in 100% of patients with secondary syphilis. False-positive tests can occur in patients with Lyme disease, leptospirosis, and diseases caused by other pathogenic Treponema spp. [2]. TTs usually remain positive for life. Polymerase-chain-reaction- (PCR-) based tests and immunoglobulin M immunoblotting tests have been developed, but they are not largely used in clinical practice. Although no Treponema pallidum detection tests are commercially available, some laboratories provide locally developed PCR tests for the detection of Treponema pallidum [2].

Prenatal diagnosis of CS includes noninvasive and invasive diagnosis. Ultrasonographic fetal examination for signs of CS is recommended prior to therapy after 20 weeks' gestation. Fetal syphilis is the presumed diagnosis when the sonographic findings of fetal hydrops, abnormally large abdomen (hepatosplenomegaly), hydramnios, and thick placenta are found in the presence of maternal syphilis [3638]. Invasive diagnosis includes amniocentesis and percutaneous umbilical blood sampling. Dark field examination, rabbit infectivity testing, and polymerase chain reaction for detection of Treponema pallidum can be performed on amniotic fluid. Hematologic and chemical testing can be performed on fetal blood and fetal antitreponemal IgM can be detected. Abnormal liver transaminases, anemia, and thrombocytopenia are signs of fetal infection. If fetal infection is suspected, antepartum fetal heart rate testing is indicated before treatment. In some cases of fetal hydrops, fetuses can have late decelerations or nonreactive nonstress testing that led to fetal distress soon after maternal treatment [36]. Evaluation of infants for suspected CS should include careful physical examination, nontreponemal serologic tests of infant serum, specimens for testing for the presence of spirochetes from mucocutaneous lesions (if these are present), complete blood count, CSF analysis (in all infants with physical findings compatible with CS quantitative nontreponemal titer >4-fold higher than the current maternal titer, or direct evidence of Treponema pallidum in clinical specimens), long bone radiographs (unless the diagnosis has been confirmed otherwise), adequate clinical tests in case of specific signs or symptoms, and pathologic examination of the placenta or umbilical cord [39].

7. Treatment

Adequate treatment of maternal infection is effective for preventing maternal transmission to the fetus and for treating fetal infection [40]. Penicillin G, administered parenterally, is the preferred drug for treating of syphilis. The effectiveness of penicillin was established through clinical experience and randomized controlled clinical trials. It provides weeks of treponemicidal levels of penicillin in the blood, but it does not efficiently cross the blood brain barrier. Aqueous crystalline penicillin G is the drug of choice for neurosyphilis treatment [7]. Treatment failure was described in few case reports, particularly in patients with HIV infection, but there is no documented penicillin resistance in T. pallidum [41]. CDC recommends that pregnant women should be treated with the penicillin regimen appropriate for their stage of infection [7]. Evidence is insufficient to determine optimal, recommended penicillin regimens [42]. In primary, secondary, and early latent syphilis, benzathine penicillin G 2.4 million units IM in a single dose is recommended [7]. Additional therapy can be beneficial for pregnant women in some settings. Some authors suggest that a second dose of benzathine penicillin 2.4 million units IM administered 1 week after the initial dose for women who have primary, secondary, or early latent syphilis [36]. In late latent syphilis or latent syphilis of unknown duration, benzathine penicillin G 7.2 million units total should be administered, as 3 doses of 2.4 million units IM each at 1 week intervals. In case of neurosyphilis, aqueous crystalline penicillin G 18–24 million units per day, administered as 3–4 million units IV every 4 hours or continuous infusion, for 10–14 days represents the suggested treatment [7]. Pregnant women who have a history of penicillin allergy should be desensitized and treated with penicillin [7, 36]. In case of HIV positive patients, placental inflammation from congenital infection might increase the risk for perinatal transmission of the virus. No sufficient data are available to recommend a specific regimen for HIV-infected pregnant women [7].

The Jarisch-Herxheimer reaction can occur in some patients 2 to 12 hours after receiving therapy for active syphilis. It is characterized by fever, headache, myalgia, and malaise, and it is caused by the release of treponemal endotoxin-like compounds during penicillin-mediated lysis [2, 43, 44]. The Jarisch-Herxheimer reaction can increase the risk of premature labor and/or fetal distress during the second half of pregnancy [45, 46]. Serologic titers should be repeated at 28–32 weeks' gestation and at delivery and should be checked monthly in women at high risk for reinfection or in high-risk geographic areas [7]. Maternal treatment can be inadequate if delivery occurs within 30 days of therapy, or if the maternal antibody titer at delivery is fourfold higher than the pretreatment titer [36].

8. Conclusions

Syphilis infection during pregnancy still represents a worldwide public health problem. The American College of Obstetricians and Gynecologists and the American Academy of Pediatrics recommend prenatal syphilis screening at the first prenatal visit and again at 32–36 weeks, if the woman is at risk for syphilis [47]. CDC recommends that all women should be screened serologically for syphilis at the first prenatal visit and, for patients at high risk, during the third trimester and at delivery [7]. Moreover, any woman who delivers a stillborn infant after 20 weeks' gestation should be tested for syphilis [36]. The Italian Guidelines of Istituto Superiore di Santità for Physiological Pregnancy (2011) stated that serological screening for syphilis should be offered to all pregnant women during the first and the third trimester of pregnancy [48]. Preconception serological tests for syphilis could represent the key to reduce the incidence of CS. Moreover, preconception counseling could play an important role, evaluating the woman and her partner for exposure to sexually transmitted diseases, identifying high-risk behaviors, and providing health promotion messages and education.

1. Berman SM. Maternal syphilis: pathophysiology and treatmentBulletin of the World Health OrganizationYear: 20048264334382-s2.0-304267421115356936
2. Ingall D,Sánchez PJ. Remington JS,Klein JOSyphilisInfectious Diseases of the Fetus and Newborn InfantYear: 20015th editionPhiladelphiaW.B. Saunders643681
3. Centers for Disease Control and Prevention National Overview of Sexually Transmitted Diseases (STDs),, 2010.
4. World Health Organization The global elimination of congenital syphilis: rationale and strategy for action,, 2007.
5. Chesson HW,Collins D,Koski K. Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United StatesCost Effectiveness and Resource AllocationYear: 200861, article 102-s2.0-45549106713
6. Blandford JM,Gift TL. The cost-effectiveness of single-dose azithromycin for treatment of incubating syphilisSexually Transmitted DiseasesYear: 20033065025082-s2.0-003794115612782951
7. Workowski KA,Berman S. Sexually transmitted diseases treatment guidelinesMorbidity and Mortality Weekly ReportYear: 201059RR-1211132-s2.0-7865062655920075837
8. Centers for Disease Control and Prevention Syphilis—CDC Fact Sheet,, 2012.
9. Centers for Disease Control and PreventionCongenital syphilis—United States, 2003–2008Morbidity and Mortality Weekly ReportYear: 2010591441341720395934
10. Centers for Disease Control and Prevention Sexually Transmitted Diseases Surveillance,, 2010.
11. World Health OrganizationTowards eliminating congenital syphilisProgress ReportYear: 2011
12. World Health Organization Regional Office for Europe. Sexually transmitted infections,, 2012.
13. Tridapalli E,Capretti MG,Sambri V,et al. Prenatal syphilis infection is a possible cause of preterm delivery among immigrant women from eastern EuropeSexually Transmitted InfectionsYear: 20078321021052-s2.0-3424814944717098768
14. Hawkes S,Matin N,Broutet N,Low N. Effectiveness of interventions to improve screening for syphilis in pregnancy: a systematic review and meta-analysisThe Lancet Infectious DiseasesYear: 20111196846912-s2.0-7995827763321683653
15. Greenblatt RM,Lukehart SA,Plummer FA,et al. Genital ulceration as a risk factor for human immunodeficiency virus infectionAIDSYear: 19882147502-s2.0-00238648923128996
16. Kent ME,Romanelli F. Reexamining syphilis: an update on epidemiology, clinical manifestations, and managementAnnals of PharmacotherapyYear: 20084222262362-s2.0-3904916975918212261
17. Goldenberg RL,Thompson C. The infectious origins of stillbirthAmerican Journal of Obstetrics and GynecologyYear: 200318938618732-s2.0-014159230114526331
18. Saloojee H,Velaphi S,Goga Y,Afadapa N,Steen R,Lincetto O. The prevention and management of congenital syphilis: an overview and recommendationsBulletin of the World Health OrganizationYear: 20048264244302-s2.0-304258602415356934
19. Jensen HB. Congenital syphilisSeminars in Pediatric Infectious DiseasesYear: 199910183194
20. Watson-Jones D,Changalucha J,Gumodoka B,et al. Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancyJournal of Infectious DiseasesYear: 200218679409472-s2.0-003678533512232834
21. Sheffield JS,Sánchez PJ,Morris G,et al. Congenital syphilis after maternal treatment for syphilis during pregnancyAmerican Journal of Obstetrics and GynecologyYear: 200218635695732-s2.0-003613047911904625
22. Saxoni F,Lapaanis P,Pantelakis SN. Congenital syphilis: a description of 18 cases and re-examination of an old but ever-present diseaseClinical PediatricsYear: 19676126876912-s2.0-00141841676061348
23. Dorfman DH,Glaser JH. Congenital syphilis presenting in infants after the newborn periodThe New England Journal of MedicineYear: 1990323129913022-s2.0-449492734212215616
24. Shah MC,Barton LL. Congenital syphilitic hepatitisPediatric Infectious Disease JournalYear: 19898128918922-s2.0-00248166022626292
25. Long WA,Ulshen MH,Lawson EE. Clinical manifestations of congenital syphilitic hepatitis: implications for pathogenesisJournal of Pediatric Gastroenterology and NutritionYear: 1984345515552-s2.0-00212653666481565
26. Bulova SI,Schwartz E,Harrer WV. Hydrops fetalis and congenital syphilisPediatricsYear: 19724922852872-s2.0-00152891585062089
27. Platou RV. Treatment of congenital syphilis with penicillinAdvances in PediatricsYear: 19494, article 35
28. Wilkinson RH,Heller RM. Congenital syphilis: resurgence of an old problemPediatricsYear: 197147127302-s2.0-00149757805545401
29. Michelow IC,Wendel GD,Norgard MV,et al. Central nervous system infection in congenital syphilisThe New England Journal of MedicineYear: 200234623179217982-s2.0-003703069912050339
30. Woods CR. Syphilis in children: congenital and acquiredSeminars in Pediatric Infectious DiseasesYear: 20051642452572-s2.0-2644446509616210105
31. Nabarro D. Congenital SyphilisYear: 1954London, UKE. Arnold
32. Rothenberg R,Becker G,Wiet R. Syphilitic hearing lossSouthern Medical JournalYear: 19797221181202-s2.0-0018354477424786
33. Sánchez PJ,Gutman LT. Feigin RD,Cherry JD,Demmler GJSyphilisTextbook of Pediatric Infectious DiseasesYear: 20045th editionPhiladelphia, Pa, USAW.B. Saunders17241743
34. Larsen SA,Steiner BM,Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilisClinical Microbiology ReviewsYear: 1995811212-s2.0-00288945127704889
35. Fischbach FT. Syphilis detection testsA Manual of Laboratory & Diagnostic TestsYear: 20006th editionPhiladelphiaLippincott581583
36. Wendel GD Jr.,Sheffield JS,Hollier LM,Hill JB,Ramsey PS,Sánchez PJ. Treatment of syphilis in pregnancy and prevention of congenital syphilisClinical Infectious DiseasesYear: 200235supplement 2S200S2092-s2.0-003710853712353207
37. Hill LM,Maloney JB. An unusual constellation of sonographic findings associated with congenital syphilisObstetrics and GynecologyYear: 19917858958972-s2.0-00260471351923219
38. Nathan L,Twickler DM,Peters MT,Sanchez PJ,Wendel GD Jr.. Fetal syphylis: correlation of sonographic findings and rabbit infectivity testing of amniotic fluidJournal of Ultrasound in MedicineYear: 1993122971012-s2.0-00273403518468743
39. Committee on Infectious Diseases and American Academy of PediatricsSyphilisRed BookYear: 2003Elk Grove Village, Ill, USAAmerican Academy of Pediatrics595607
40. Alexander JM,Sheffield JS,Sanchez PJ,Mayfield J,Wendel GD Jr.. Efficacy of treatment for syphilis in pregnancyObstetrics and GynecologyYear: 1999931582-s2.0-00326213859916946
41. Stamm LV. Global challenge of antibiotic-resistant Treponema pallidumAntimicrobial Agents and ChemotherapyYear: 20105425835892-s2.0-7574912344219805553
42. Walker GJ. Antibiotics for syphilis diagnosed during pregnancyCochrane Database of Systematic ReviewsYear: 20013CD0011432-s2.0-0035231542
43. Murray ML. Jarisch-Herxheimer reactionJournal of Obstetric, Gynecologic, and Neonatal NursingYear: 1996259p. 7312-s2.0-0030279341
44. Singh YP,Jalpota G. Jarisch-Herxheimer reaction in early syphilisIndian Journal of Dermatology, Venereology and LeprologyYear: 1995616, article 386
45. Klein VR,Cox SM,Mitchell MD,Wendel GD Jr.. The Jarisch-Herxheimer reaction complicating syphilotherapy in pregnancyObstetrics and GynecologyYear: 1990753 I3753802-s2.0-00250178352304710
46. Myles TD,Elam G,Park-Hwang E,Nguyen T. The Jarisch-Herxheimer reaction and fetal monitoring changes in pregnant women treated for syphilisObstetrics and GynecologyYear: 19989258598642-s2.0-00317359989794683
47. American Academy of Pediatrics and American College of Obstetricians GynecologistsAntepartum careGuidelines for Perinatal CareYear: 20076th editionElk Grove Village, Ill, USAAmerican Academy of Pediatrics87137
48. Istituto Superiore di Sanità Linee Guida per la gravidanza fisiologica,, 2011.

Article Categories:
  • Review Article

Previous Document:  BioParishodhana: A novel graphical interface integrating BLAST, ClustalW, primer3 and restriction di...
Next Document:  Utility and safety of ERCP in the elderly: a comparative study in iran.